Changing clinical and pathological features of gastric cancer over time
- PMID: 21560122
- DOI: 10.1002/bjs.7528
Changing clinical and pathological features of gastric cancer over time
Abstract
Background: The aim of the present multicentre observational study was to evaluate potential changes in clinical and pathological features of patients with gastric cancer (GC) treated in a 15-year interval.
Methods: A centralized prospective database including clinical, surgical, pathological and follow-up data from 2822 patients who had resection of a primary GC was analysed. The analysis focused on three periods: 1991-1995 (period 1), 1996-2000 (period 2) and 2001-2005 (period 3). Surgical procedure, pathological classification and follow-up were standardized among centres.
Results: The number of resections decreased from 1024 in period 1 to 955 and 843 in periods 2 and 3 respectively. More advanced stages and a smaller number of intestinal-type tumours of the distal third were observed over time. Five-year survival rates after R0 resection (2320 patients) did not change over time (overall: 56·6 and 51·2 per cent in periods 1 and 3; disease-free: 66·8 and 61·1 per cent respectively). Decreases in survival in more recent years were related particularly to more advanced stage, distal tumours and tumours in women. Multivariable analysis showed a lower probability of overall and disease-free survival in the most recent interval: hazard ratio 1·22 (95 per cent confidence interval 1·06 to 1·40) and 1·29 (1·06 to 1·58) respectively compared with period 1. Recurrent tumours were more frequently peritoneal rather than locoregional.
Conclusion: Overall and disease-free survival rates after R0 resection of GC were unchanged over time.
Copyright © 2011 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
Similar articles
-
Cancer of the gastric stump following distal gastrectomy for cancer.Br J Surg. 2007 Jan;94(1):92-5. doi: 10.1002/bjs.5538. Br J Surg. 2007. PMID: 17054314
-
The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.J Am Coll Surg. 1995 Jul;181(1):56-64. J Am Coll Surg. 1995. PMID: 7599772
-
Secular trends in the use, quality, and outcomes of gastrectomy for noncardia gastric cancer in the United States.Ann Surg Oncol. 2007 Sep;14(9):2519-27. doi: 10.1245/s10434-007-9386-8. Epub 2007 Jul 3. Ann Surg Oncol. 2007. PMID: 17610016
-
[Surgical outcome of 801 patients with localized gastric cancer treated with d2 lymphadenectomy].Rev Gastroenterol Peru. 2009 Apr-Jun;29(2):124-31. Rev Gastroenterol Peru. 2009. PMID: 19609327 Spanish.
-
[Stage-adapted radical principles in gastric carcinoma].Praxis (Bern 1994). 1998 Mar 25;87(13):447-50. Praxis (Bern 1994). 1998. PMID: 9584570 Review. German.
Cited by
-
Clinical impact of molecular classifications in gastric cancer.Updates Surg. 2018 Jun;70(2):225-232. doi: 10.1007/s13304-018-0546-0. Epub 2018 May 23. Updates Surg. 2018. PMID: 29796937 Review.
-
Gastric cancer: Current status of lymph node dissection.World J Gastroenterol. 2016 Mar 14;22(10):2875-93. doi: 10.3748/wjg.v22.i10.2875. World J Gastroenterol. 2016. PMID: 26973384 Free PMC article. Review.
-
Premedication with simethicone and N-acetylcysteine for improving mucosal visibility during upper gastrointestinal endoscopy in a Western population.Endosc Int Open. 2021 Feb;9(2):E190-E194. doi: 10.1055/a-1315-0114. Epub 2021 Jan 25. Endosc Int Open. 2021. PMID: 33532557 Free PMC article.
-
A novel approach of optical biopsy using probe-based confocal laser endomicroscopy for peritoneal metastasis.Surg Endosc. 2016 Aug;30(8):3437-46. doi: 10.1007/s00464-015-4626-7. Epub 2015 Nov 5. Surg Endosc. 2016. PMID: 26541741
-
Drug-induced senescence by aurora kinase inhibitors attenuates innate immune response of macrophages on gastric cancer organoids.Cancer Lett. 2024 Aug 28;598:217106. doi: 10.1016/j.canlet.2024.217106. Epub 2024 Jul 9. Cancer Lett. 2024. PMID: 38992487 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous